These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17109389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation.
    Mc Lornan DP, Percy MJ, Jones AV, Cross NC, Mc Mullin MF.
    Haematologica; 2005 Dec; 90(12):1696-7. PubMed ID: 16330446
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chronic neutrophilic leukemia with congenital Robertsonian translocation successfully treated with allogeneic bone marrow transplantation in a young man.
    Goto H, Hara T, Tsurumi H, Tanabashi S, Moriwaki H.
    Intern Med; 2009 Dec; 48(7):563-7. PubMed ID: 19336960
    [Abstract] [Full Text] [Related]

  • 6. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Dec; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): case report.
    Choi IK, Kim BS, Lee KA, Ryu S, Seo HY, Sul H, Choi JG, Sung HJ, Park KH, Yoon SY, Oh SC, Seo JH, Choi CW, Shin SW, Yoon SY, Cho Y, Kim YK, Kim YH, Kim JS.
    Am J Hematol; 2004 Dec; 77(4):366-9. PubMed ID: 15551277
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.
    Wang YL, Lee JW, Kui JS, Chadburn A, Cross NC, Knowles DM, Coleman M.
    Acta Haematol; 2007 Dec; 118(4):209-14. PubMed ID: 18032883
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia.
    Lea NC, Lim Z, Westwood NB, Arno MJ, Gäken J, Mohamedali A, Mufti GJ.
    Leukemia; 2006 Jul; 20(7):1324-6. PubMed ID: 16673022
    [No Abstract] [Full Text] [Related]

  • 17. Chronic neutrophilic leukemia: a contemporary review.
    Elliott MA.
    Curr Hematol Rep; 2004 May; 3(3):210-7. PubMed ID: 15087070
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.